MucoLife Therapeutics Secures SEK 1M from Vinnova to Advance COPD Drug Development
Swedish biotech company MucoLife Therapeutics AB has received SEK 1 million in funding from Vinnova, Sweden’s innovation agency. The grant was awarded through a programme that supports small and medium-sized…